These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [Nuclear factor κB and IKB expression and calcium deposition of atherosclerotic plaques in apolipoprotein E and low density lipoprotein receptor knockout mice]. Yang FZ; Zhou J; Li WW; Wang F; Wen PY; Zhou L; Wang JG; Zheng XX Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Aug; 40(8):684-9. PubMed ID: 23141015 [TBL] [Abstract][Full Text] [Related]
30. Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice. Karavia EA; Papachristou DJ; Kotsikogianni I; Giopanou I; Kypreos KE FEBS J; 2011 Sep; 278(17):3119-29. PubMed ID: 21740524 [TBL] [Abstract][Full Text] [Related]
31. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. Moore KJ; Kunjathoor VV; Koehn SL; Manning JJ; Tseng AA; Silver JM; McKee M; Freeman MW J Clin Invest; 2005 Aug; 115(8):2192-201. PubMed ID: 16075060 [TBL] [Abstract][Full Text] [Related]
32. No effect of C-reactive protein on early atherosclerosis in LDLR-/- / human C-reactive protein transgenic mice. Torzewski M; Reifenberg K; Cheng F; Wiese E; Küpper I; Crain J; Lackner KJ; Bhakdi S Thromb Haemost; 2008 Jan; 99(1):196-201. PubMed ID: 18217154 [TBL] [Abstract][Full Text] [Related]
33. Apoptotic cell death in atherosclerotic plaques of hyperlipidemic knockout mice. Harada K; Chen Z; Ishibashi S; Osuga J; Yagyu H; Ohashi K; Yahagi N; Shionoiri F; Sun L; Yazaki Y; Yamada N Atherosclerosis; 1997 Dec; 135(2):235-9. PubMed ID: 9430373 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice. Schönbeck U; Sukhova GK; Shimizu K; Mach F; Libby P Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7458-63. PubMed ID: 10861012 [TBL] [Abstract][Full Text] [Related]
35. Disruption of SEMA4D ameliorates platelet hypersensitivity in dyslipidemia and confers protection against the development of atherosclerosis. Zhu L; Stalker TJ; Fong KP; Jiang H; Tran A; Crichton I; Lee EK; Neeves KB; Maloney SF; Kikutani H; Kumanogoh A; Pure E; Diamond SL; Brass LF Arterioscler Thromb Vasc Biol; 2009 Jul; 29(7):1039-45. PubMed ID: 19390055 [TBL] [Abstract][Full Text] [Related]
36. Increased primary tumor growth in mice null for beta3- or beta3/beta5-integrins or selectins. Taverna D; Moher H; Crowley D; Borsig L; Varki A; Hynes RO Proc Natl Acad Sci U S A; 2004 Jan; 101(3):763-8. PubMed ID: 14718670 [TBL] [Abstract][Full Text] [Related]
37. Increased atherosclerosis in hyperlipidemic mice deficient in alpha -tocopherol transfer protein and vitamin E. Terasawa Y; Ladha Z; Leonard SW; Morrow JD; Newland D; Sanan D; Packer L; Traber MG; Farese RV Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13830-4. PubMed ID: 11095717 [TBL] [Abstract][Full Text] [Related]
38. Proatherogenic effect of interleukin-18 is exerted with high-fat diet, but not with normal diet in spontaneously hyperlipidemic mice. Imai T; Oikawa Y; Shimada A; Oguchi S; Takamiya Y; Katsuki T; Okubo Y; Osaki T; Tahara H; Matsushima Y; Miyazaki J; Itoh H J Atheroscler Thromb; 2011; 18(12):1090-101. PubMed ID: 21931227 [TBL] [Abstract][Full Text] [Related]
39. Comparative proteomic analysis of a cytosolic fraction from β3 integrin-deficient cells. Bush JA; Kitaura H; Ma Y; Teitelbaum SL; Ross FP; Smith JW Cancer Genomics Proteomics; 2012 Jan; 9(1):1-13. PubMed ID: 22210044 [TBL] [Abstract][Full Text] [Related]
40. Alpha-v beta-3 integrin expression in normal and atherosclerotic artery. Hoshiga M; Alpers CE; Smith LL; Giachelli CM; Schwartz SM Circ Res; 1995 Dec; 77(6):1129-35. PubMed ID: 7586225 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]